Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegbelfermin in NASH with Stage 3 Liver Fibrosis (FALCON 1)
NCT03486899Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2018
- Primary completion
- Sep 2020
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 2 trial of pegbelfermin in Nonalcoholic steatohepatitis (NASH), sponsored by Bristol Myers Squibb. Started Jun 2018; status: completed.
02
Drugs
pegbelfermin
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT03486899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03486899.